| Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity, survival, and six-month sequelae in COVID-19 symptomatic patients M Trunfio, F Venuti, F Alladio, BM Longo, E Burdino, F Cerutti, V Ghisetti, ... Viruses 13 (2), 281, 2021 | 69 | 2021 |
| Co-infection with other respiratory pathogens in COVID-19 patients A Calcagno, V Ghisetti, E Burdino, M Trunfio, T Allice, L Boglione, ... Clinical Microbiology and Infection 27 (2), 297-298, 2021 | 59 | 2021 |
| Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern M Trunfio, A Savoldi, O Viganò, A d’Arminio Monforte Infection 45, 1-10, 2017 | 51 | 2017 |
| The role of antirheumatics in patients with COVID-19 CB Nissen, S Sciascia, D de Andrade, T Atsumi, IN Bruce, RQ Cron, ... The Lancet Rheumatology 3 (6), e447-e459, 2021 | 46 | 2021 |
| Risk for SARS-CoV-2 infection in healthcare workers, Turin, Italy A Calcagno, V Ghisetti, T Emanuele, M Trunfio, S Faraoni, L Boglione, ... Emerging Infectious Diseases 27 (1), 303, 2021 | 37 | 2021 |
| A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs I De Benedetto, M Trunfio, G Guastamacchia, S Bonora, A Calcagno Journal of neurovirology 26, 642-651, 2020 | 29 | 2020 |
| Factors associated with severe COVID-19 and post-acute COVID-19 syndrome in a cohort of people living with HIV on antiretroviral treatment and with undetectable HIV RNA M Mazzitelli, M Trunfio, L Sasset, D Leoni, E Castelli, S Lo Menzo, ... Viruses 14 (3), 493, 2022 | 24 | 2022 |
| Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection M Trunfio, E Salvador, D Cabodi, L Marinaro, C Alcantarini, A Gaviraghi, ... Thrombosis Research 196, 432-434, 2020 | 24 | 2020 |
| Diagnostic accuracy of new and old cognitive screening tools for HIV‐associated neurocognitive disorders M Trunfio, D Vai, C Montrucchio, C Alcantarini, A Livelli, MC Tettoni, ... HIV medicine 19 (7), 455-464, 2018 | 24 | 2018 |
| Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? M Trunfio, C Pinnetti, E Focà, F Bai, G Maffongelli, L Celani, P Cinque, ... AIDS 33 (4), 759-762, 2019 | 22 | 2019 |
| Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid A Palazzo, M Trunfio, V Pirriatore, M Milesi, A De Nicolò, C Alcantarini, ... Journal of Antimicrobial Chemotherapy 73 (3), 826-827, 2018 | 21 | 2018 |
| CNS-targeted antiretroviral strategies: when are they needed and what to choose A Calcagno, A Barco, M Trunfio, S Bonora Current HIV/AIDS Reports 15, 84-91, 2018 | 20 | 2018 |
| What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system? SB Joseph, M Trunfio, LP Kincer, A Calcagno, RW Price Aids 33, S171-S179, 2019 | 19 | 2019 |
| Real-life evidence of lower lung virulence in COVID-19 inpatients infected with SARS-CoV-2 omicron variant compared to wild-type and delta SARS-CoV-2 pneumonia M Trunfio, F Portesani, S Vicinanza, P Nespoli, F Traverso, G Cortese, ... Lung 200 (5), 573-577, 2022 | 17 | 2022 |
| Alzheimer dementia in people living with HIV A Calcagno, L Celani, M Trunfio, G Orofino, D Imperiale, C Atzori, V Arena, ... Neurology: Clinical Practice 11 (5), e627-e633, 2021 | 17 | 2021 |
| On the SARS-CoV-2 “variolation hypothesis”: no association between viral load of index cases and COVID-19 severity of secondary cases M Trunfio, BM Longo, F Alladio, F Venuti, F Cerutti, V Ghisetti, S Bonora, ... Frontiers in Microbiology 12, 646679, 2021 | 17 | 2021 |
| Older age is associated with higher dolutegravir exposure in plasma and cerebrospinal fluid of people living with HIV A Calcagno, J Moltó, A Borghetti, C Gervasoni, M Milesi, M Valle, ... Clinical Pharmacokinetics 60, 103-109, 2021 | 16 | 2021 |
| Blood–brain barrier impairment in patients living with HIV: predictors and associated biomarkers G Caligaris, M Trunfio, V Ghisetti, J Cusato, M Nigra, C Atzori, D Imperiale, ... Diagnostics 11 (5), 867, 2021 | 15 | 2021 |
| The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series TYH Chan, V De Zan, A Gregg, J Alagaratnam, S Gerevini, A Antinori, ... AIDS 35 (14), 2341-2346, 2021 | 13 | 2021 |
| Cerebrospinal fluid viral load across the spectrum of untreated human immunodeficiency virus type 1 (HIV-1) infection: a cross-sectional multicenter study G Ulfhammer, A Edén, A Antinori, BJ Brew, A Calcagno, P Cinque, ... Clinical Infectious Diseases 75 (3), 493-502, 2022 | 12 | 2022 |
